United Therapeutics (NASDAQ: UTHR) pushes inhaled therapy strategy as Phase 3 Tyvaso data shows lung function preservation in IPF
Read More 2 minute read Pharma Industry News Boehringer Ingelheim’s SENVELGO gets EU marketing authorization for feline diabetes treatment The European Commission has granted marketing authorization to Boehringer Ingelheim for SENVELGO (active ingredient: velagliflozin), a groundbreaking development… byPallavi MadhirajuNovember 23, 2023